Fernando Warley
@FernandoWarley5
The overall frequency of BTK mutations was low in zanubrutinib- and ibrutinib-treated patients experiencing early CLL progression in the ALPINE study. ow.ly/uZSp50VFKiU #clinicaltrialsandobservations #lymphoidneoplasia
Hemos llevado a cabo las "3ras Jornadas de Residentes y Hematólogos Jóvenes" en Rosario. Un enorme orgullo seguir realizando estas Jornadas de educación médica tan enriquecedoras. ¡Muchas gracias Dr. Julio Pose Cabarcos y Dr. José Luis Fedele por su participación! #beigene
Check out our 2 posters: Long term follow up of Pet adapted therapy in all stages of HL and RWE of use of consolidation of BV post auto. @FiadLorena. Nice visita from @CarlosChiattone and @Evadodo23 @icmlugano #ICML2025
ICML 2025 Lugano🤩🤩 An excellent experience! The Great Debate was amazing! MD Cwynarsky was clear: there’s still no evidence to support CNS prophylaxis for all!
#EHA2025 Gracias @FernandoWarley5 y @BeOneMedicines @Grupo_GELL
If you happen to attend today’s poster session at #EHA2025, walk through PS1859 and learn more about the “IMPACT OF #AGE, #FRAILTY AND #COMORBIDITIES IN THE #SURVIVAL OF OLDER PATIENTS WITH #HODGKIN #LYMPHOMA: A RETROSPECTIVE STUDY OF @geltamo” #lymsm #geriheme
Just out: @jco SEQUOIA arm D results published simultaneously with the @ASCO presentation. Great efficiency and safety of Zanu plus Ven in #CLL regardless of TP53 aberration. @fredhutch @uwmnewsroom #ASCO25
‼️ #ASCO25 simultaneous publication by @mshadman et al: Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results: brnw.ch/21wT3Ph
Challenges in managing and reporting adverse events in haematological malignancies in low-income and middle-income countries - The Lancet Haematology thelancet.com/journals/lanha…
📍 Día 2 | Jornadas GATMO @SAHematologia Cerramos dos días de altísimo nivel académico en trasplante y terapia celular, con gran participación de colegas de toda Argentina y Latinoamérica. #GATMO #SAH #Hematología #Trasplante #TerapiaCelular
Clinical research so important for our patients = new tx options + better care ✅
So much change in R/R #DLBCL over recent years! See the updated @BritSocHaem guidelines now online onlinelibrary.wiley.com/doi/10.1111/bj…
Siempre lindo volver al hospital que me vio recibirme de medico.. Hospital Posadas 🫶🏻 Y gracias al hospital Pirovano por recibirme tb para este nuevo ciclo de charlas! #BeiGene #MedicalAffaires #cll #mcl
📚 La @SAHematologia continúa fortaleciendo la formación médica a través de sus actividades académicas: cursos, jornadas, focos y ateneos. Comprometidos con el desarrollo profesional continuo y la excelencia en hematología. #SAH #Hematología #EducaciónMédica